tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (PL:RVU)
:RVU
Poland Market

Ryvu Therapeutics SA (RVU) Financial Statements

Compare
0 Followers

Ryvu Therapeutics SA Financial Overview

Ryvu Therapeutics SA's market cap is currently zł639.27M. The company's EPS TTM is zł-1.069; its P/E ratio is -5.39; Ryvu Therapeutics SA is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is zł―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuezł 77.97Mzł 46.86Mzł 38.80Mzł 11.19Mzł 15.41M
Gross Profitzł 58.39Mzł 29.31Mzł 21.40Mzł -2.54Mzł 6.65M
Operating Incomezł -122.10Mzł -100.95Mzł -78.42Mzł -103.78Mzł -35.70M
EBITDAzł -96.83Mzł -81.04Mzł -65.21Mzł -65.96Mzł -17.87M
Net Incomezł -111.44Mzł -92.11Mzł -83.78Mzł -79.08Mzł -31.69M
Balance Sheet
Cash & Short-Term Investmentszł 225.40Mzł 233.67Mzł 102.44Mzł 88.23Mzł 161.19M
Total Assetszł 378.78Mzł 403.20Mzł 474.98Mzł 228.81Mzł 295.64M
Total Debtzł 75.51Mzł 906.00Kzł 2.77Mzł 5.07Mzł 7.41M
Net Debtzł -84.56Mzł -57.03Mzł -99.15Mzł -78.17Mzł -128.81M
Total Liabilitieszł 234.89Mzł 143.61Mzł 131.59Mzł 59.39Mzł 71.92M
Stockholders' Equityzł 143.88Mzł 259.59Mzł 343.39Mzł 161.30Mzł 223.72M
Cash Flow
Free Cash Flowzł -135.38Mzł -88.11Mzł 12.03Mzł -69.85Mzł -44.82M
Operating Cash Flowzł -129.48Mzł -84.55Mzł 21.32Mzł -57.87Mzł -10.64M
Investing Cash Flowzł 137.16Mzł -195.54Mzł 690.00Kzł 8.06Mzł -55.94M
Financing Cash Flowzł 94.21Mzł 240.83Mzł -2.46Mzł -3.17Mzł 130.69M
Currency in PLN

Ryvu Therapeutics SA Earnings and Revenue History

Ryvu Therapeutics SA Debt to Assets

Ryvu Therapeutics SA Cash Flow

Ryvu Therapeutics SA Forecast EPS vs Actual EPS